@article {e0fcf42ab4d0496fac17f112d1a18089,
	title = {The QcrB inhibitors TB47 and telacebec do not potentiate the activity of clofazimine in mycobacterium abscessus},
	journal = {Antimicrobial Agents and Chemotherapy},
	volume = {65},
	number = {12},
	year = {2021},
	note = {Publisher Copyright: Copyright {\textcopyright} 2021 American Society for Microbiology. All Rights Reserved.},
	month = {dec},
	publisher = {American Society for Microbiology},
	abstract = {The antituberculosis drug telacebec is ineffective against Mycobacterium abscessus. A recent study suggested that TB47, a telacebec analogue, potentiated the efficacy of clofazimine against M. abscessus. Here, we report that TB47 not only is ineffective against M. abscessus in vitro but also does not potentiate the activity of clofazimine.},
	keywords = {Cytochrome bcc:aa, Nontuberculous mycobacteria, Oxidative Phosphorylation, Q203, Terminal oxidase, tuberculosis},
	issn = {0066-4804},
	doi = {10.1128/AAC.00964-21},
	author = {Ria Sorayah and Moraski, Garret C. and Daniel Barkan and Kevin Pethe}
}
